The long way back from the turn lane in front of Dino's Bar and Grill

The Department of Hearing and Speech Sciences has conducted research to better understand how individuals with traumatic brain injury (TBI) have adapted to the COVID-19 pandemic. Researchers think the findings may apply to many disability populations in future crises.

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

A simple message that can save lives and help life get back to normal

The mural inside Vanderbilt University Adult Hospital depicts several Nashville music legends giving a standing ovation to a health care worker in honor of National Nurses Week.

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

The flexibility and adaptability of Vanderbilt University Medical Center has been center stage as the pressures of COVID-19 and ongoing strategic imperatives have transformed how and where care is delivered.